Overview

Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study is multicenter, Ph IV, single arm, interventional study to assess relative reduction of morning stiffness of Lodotra® in Rheumatoid Arthritis patients.Study medication will start after study visit at baseline (week 0, visit 1) and follow-up visit will be after 2, 6 and 12 weeks after treatment (visit 2,3,4).
Phase:
Phase 4
Details
Lead Sponsor:
Mundipharma Korea Ltd
Treatments:
Prednisone